Royal Free & University College London
Coronary heart disease and the clinical potential of pharmacogenetics are discussed
Published in Cardiovascular Device Liability Week, April 2nd, 2006
According to the review, "Much has been written about the potential of pharmacogenetic testing to inform therapy based on an individual's genetic makeup, and to decide the most effective choice of available drugs, or to avoid dangerous side effects. Currently, there is little hard data for either in the field of cardiovascular disease."
S.E. Humphries and A. Hingorani of the Royal Free & University College in London explained, "The usual approach has been opportunistic use of drug...
Want to see the full article?
We're a pay-per-view site for premium content. If you'd like to purchase this article, it's only $3.00.
Welcome to NewsRx!
Learn more about a six-week, no-risk free trial of Cardiovascular Device Liability Week
More Articles from Cardiovascular Device Liability Week
- CardioTech International, Inc.
Andrew M. Reed, PhD, named VP of technology by CardioTech - Local Health Unit 10, Florence
Acute myocardial infarction patients of increased age, comorbidity tend to be excluded from CRT - Public Library of Science
Legal and ethical questions about human embryonic stem cell research still unanswered - Schepens Eye Research Institute, Boston
Adult blood vessels are stabilized by vascular endothelial growth factor - Universidade Federal de Sao Paulo
APO A-V-1131T->C polymorphism frequency linked to morbidity in elderly population - Akita University
During CPR, injuries to the cardiac conduction system occur in limited regions - More from this issue of Cardiovascular Device Liability Week
NewsRx is Social
Follow us on your favorite social network by clicking on a button below:
Top Medical Newsletters
Awards
Best Health/Healthcare Content, 2012
Best Health/Healthcare Content, 2011
Best e-Business Site, 2010
Best e-Business Site, 2009
Best e-Business Site, 2008
Best e-Business Site, 2007
Best e-Business Site, 2006
Best Healthcare Content, 2005
Best Overall Internet Site, 2005
Best Interactive Site, 2005
Facts & Stats
NewsRx also is available at LexisNexis, Gale, ProQuest, Factiva, Dialog, Thomson Reuters, NewsEdge, and Dow Jones.
- Google 2010 PageRank: #2 Among Top Health News and Media Publications
- Google 2010 PageRank: #2 Among Top Science Publications in Biology/Physiology
- Google 2010 PageRank: #2 Among Top News and Media for the Business of Pharmaceuticals
- Amazon's Alexa 2010 PageRank: #2 News and Media Site for the Pharmaceutical Industry
